Citalopram-induced bruxism

2001/02/01 by M. E. J. Wise, Mark E. Wise · 6 citations
Medicine · #Pharmacological Effects and Toxicity Studies #Epilepsy research and treatment #Neurological and metabolic disorders

paper · pdf · doi:10.1192/bjp.178.2.182

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.

Cited by

• Assessment of self-reported and clinically reported bruxism in studies on selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors use
• Buspirone use in the treatment of atomoxetine-induced bruxism. [europepmc]
• Current Treatments of Bruxism. [europepmc]
• Health impact of human rights testimony: harming the most vulnerable? [europepmc]
• Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's Disease. [europepmc]
• The neural substrates of bruxism: current knowledge and clinical implications. [europepmc]

Related

• The pain and mental health comorbidity
• UK Head and Neck Cancer Multidisciplinary Guidelines – lay summary for non-clinicians
• Navigating recurrent <i>Clostridioides difficile</i> infection without Bezlotoxumab: potential challenges ahead
• Penicillin allergy labels and antibiotic prescribing in carceral settings: expanding evidence from a statewide cohort
• How to put psychiatrists back at the centre of medicine’s innovation